You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

North America Realizing Robust Capital Spending For Biologics Manufacturing Facilities, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 90 Words
Attachment: Biologics

Biologics are products that are produced from living organisms or contain components of living organisms. Examples include vaccines, plasmas, cell/gene therapies, active pharmaceutical ingredients (APIs) and antigens. Manufacturing firms such as Merck, CSL Behring, Pfizer, Sanofi Pasteur and Gilead/Kite are continuing to heavily invest in their North American manufacturing facilities.

Industrial Info is tracking 179 major capital projects in this sector in the U.S. and Canada with a total investment value of about $11 billion.

Subscribe Now! All Fields Required...

Standard Membership - Free